Idera Pharma (IDRA) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharma (NASDAQ: IDRA) reported Q4 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Idera Pharma (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Genco rejects Diana Shipping bid, calls offer below NAV
- Genco rejects Diana Shipping takeover bid as undervalued
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
